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Abstract
In retrospective radiation treatment (RT) dosimetry, a surrogate anatomy is
often used for patients without 3D CT. To gain insight in what the crucial
aspects in a surrogate anatomy are to enable accurate dose reconstruction, we
investigated the relation of patient characteristics and internal anatomical
features with deviations in reconstructed organ dose using surrogate patient’s
CT scans. Abdominal CT scans of 35 childhood cancer patients (age:
2.1–5.6 yr; 17 boys, 18 girls) undergoing RT during 2004–2016 were inclu-
ded. Based on whether an intact right or left kidney is present in the CT scan,
two groups were formed each containing 24 patients. From each group, four
CTs associated with Wilms’ tumor RT plans with an anterior-posterior—
posterior-anterior field setup were selected as references. For each reference, a
2D digitally reconstructed radiograph was computed from the reference CT to
simulate a 2D radiographic image and dose reconstruction was performed on
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the other CTs in the respective group. Deviations in organ mean dose (DEmean)
of the reconstructions versus the references were calculated, as were deviations
in patient characteristics (i.e. age, height, weight) and in anatomical features
including organ volume, location (in 3D), and spatial overlaps. Per reference,
the Pearson’s correlation coefficient between deviations in DEmean and patient
characteristics/features were studied. Deviation in organ locations and DEmean
for the liver, spleen, and right kidney were moderately correlated (R2>0.5)
for 8/8, 5/8, and 3/4 reference plans, respectively. Deviations in organ
volume or spatial overlap and DEmean for the right and left kidney were weakly
correlated (0.3<R2<0.5) in 4/4 and 1/4 reference plans. No correlations
(R2<0.3) were found between deviations in age or height and DEmean.
Therefore, the performance of organ dose reconstruction using surrogate
patients’ CT scans is primarily related to deviation in organ location, followed
by volume and spatial overlap. Further, results were plan dependent.
Keywords: dose reconstruction, dose comparison, anatomical variation,
childhood cancer, abdominal tumors
(Some figures may appear in colour only in the online journal)
1. Introduction
Childhood cancer patients are cured about 80% of the times nowadays. Compared to adult
cancer patients, they have a longer life expectancy, but a lower tolerance to ionizing radiation
[1, 2]. Thus, childhood cancer survivors that received radiation treatment (RT) are more prone
to late adverse effects in their lifetime [1, 3]. Having precise knowledge of dose to organs at
risk (OARs) during treatment could enable understanding of the radiation dose and late
adverse effects relationship, and ultimately improve the design of future treatments. However,
obtaining dose to OAR information is hampered by the fact that the majority of patients with
long-term (>20 years) follow-up were treated in the era when 2D radiographic images taken
by a radiotherapy simulator were used for RT field localisation and dose calculation (e.g. pre-
1990s in the Netherlands) [4, 5]. 3D dose distributions are therefore absent.
To address the absence of 3D images for these patients, various dose reconstruction
methods have been developed. Phantom-based methods provide either physical measure-
ments or dose computation, using physical or computational phantoms that simulate the
human anatomy, respectively [5]. Compared to physical phantoms with fixed geometries,
computational phantoms have advantages in versatility, efficiency, and safety. The recently
introduced ‘hybrid’ computational phantoms combine voxel-based images with advanced
boundary representation methods that allow organ reshaping and repositioning, achieving
both realistic and flexible anatomy [6–9].
Phantoms were originally used in prospective dosimetry studies for radiological pro-
tection purposes [9]. So-called reference phantoms were designed to simulate the repre-
sentative anatomy of a specific age and gender in the population matching the published
reference human anthropomorphic values [6, 10, 11]. However, anatomical variations exist in
the population both in the outer body and in internal anatomy [12]. Also, in RT dosimetry,
rather than a low, homogeneous dose over the scanned body volume as in CT exams, the dose
distribution is mostly heterogeneous in the region of interest as high dose is delivered to the
tumor site and surrounding normal tissues are blocked as much as possible. Therefore, for
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retrospective individualised RT dosimetry studies, the accuracy of a dose reconstruction
largely depends on how similar the geometry of the phantom was to the specific geometry of
the individual patient [9, 13]. While phantom libraries were developed to provide more
variability in anatomies [14–18], it is still not clear how to best select/deform a phantom for a
patient for whom 3D image data is absent. A recent study on CT dosimetry matched phan-
toms by age and gender, height and weight, and water equivalent diameter (defined as average
of the scanned range of the body), and found the average difference in organ mean dose to be
24%, 14% and 12%, respectively [19]. In a study on RT dosimetry, it was shown that lungs
and heart shape, visible in 2D radiographs, could guide the deformation of a 3D organ model
to provide satisfactory organ dose reconstruction results (<=0.3 Gy mean organ dose
deviation in lungs, heart, and breasts) [20].
Studies using pediatric phantom libraries are rather scarce, and limited in variability in
internal anatomy [11, 17, 18]. The availability of CT scans, acquired for RT planning pur-
poses of recently-treated childhood cancer patients, provides possibilities for creation of a
library of CT scans that represents the anatomical variations among childhood cancer patients.
The idea is that one of the CT scans from the library can be selected that closely resembles the
historically-treated patient’s anatomy to perform 3D organ dose reconstruction. However, the
available data of the historically-treated patients is limited, and it is yet unknown how to best
select the corresponding surrogate CT scan.
In a previous study, we assessed a 2D-to-3D dose reconstruction approach (3D dose
reconstruction for patients with only 2D imaging data available) using age- and gender-
matched surrogate CTs , which is the literature standard of matching patients for organ dose
reconstruction purposes [21]. We focused on abdominal CTs of childhood cancer patients and
Wilms’ tumor (the most common type of kidney cancer in children) RT plans, which in the
2D-era were planned on abdominal anterior-posterior—posterior-anterior (AP-PA) simulator
films [22]. Although for a subset of reconstructions the obtained dose reconstruction errors
were small, the use of an age- and gender-matched surrogate CT scan did not guarantee
sufficient accuracy [21]. Since geometrical differences in anatomy were considered to be the
source of dose reconstruction uncertainty [9, 13], it is expected that a better understanding of
patient characteristics (e.g. height) and internal anatomical features (e.g. organ location) in
relation to organ dose reconstruction accuracy will benefit the selection of the best-matched
surrogate CT scan(s). Moreover, ongoing research is assessing the feasibility of modeling
internal anatomy based on parameters that are available in the 2D setting (e.g. height,
anatomy visible in 2D radiographs) [23, 24].
In this study, we investigated the correlation of a selection of patient characteristics and
internal anatomical features with organ dose reconstruction accuracy. Again, we focused on
recently used Wilms’ tumor RT plans in our medical center, as for these an AP-PA field setup
similar to historical abdominal RT planning was still applied. Different from the previous
study, we did not select surrogate CTs based on pre-assumed matching criteria such as age
and gender, but used all available CTs as surrogates. Furthermore, we quantified deviations in
patient characteristics and anatomical features and investigated their relation to dose recon-
struction accuracy.
2. Materials and methods
A flowchart illustrating our approach is presented in figure 1. The key idea is that reference
data (each reference plan with associated reference CT) are used to simulate a patient for
whom only 2D data is available. Therefore, a digitally-reconstructed-radiograph (DRR) is
J. Radiol. Prot. 39 (2019) 598 Z Wang et al
600
created from the reference CT to simulate the historical radiograph and the reference RT fields
are projected on this DRR. However, for the internal anatomical feature extraction and
reference dose calculation, the actual reference CT is used, to enable comparison with the
surrogate CTs and the reconstructed doses. This will be explained in more detail in the
following sections.
2.1. Data preparation
We retrospectively included a cohort of 35 childhood cancer patients, who received RT at the
Academic Medical Center/Emma Children’s Hospital (AMC) (n=33) or at the University
Figure 1. Pipeline of the methodology. From the 35 planning CTs, two groups of 24
CTs each are formed: GL (with left kidney) and GR (with right kidney) (block 1-A). In
block 1-B, a reference plan with associated CT is selected from the GL group and the
remaining 23 CTs are used as surrogate CTs. In block 2, (a) illustrates the DRR (AP
view) derived from the reference CT with the effective field borders of the reference
plan (in solid yellow lines), and (b) illustrates the DRRs derived from the surrogate CTs
with the adjusted field borders of the reference plan (only one case fully visible). The
yellow cross points indicate the field isocenters. Further, patient characteristic/feature
deviations are extracted and correlations with dose deviations are investigated (blocks 3
and 4).
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Medical Center Utrecht/Princess Máxima Center for Pediatric Oncology (UMC Utrecht)
(n=2) from 2004 to 2016, for whom CT scans of the abdomen were available. Data were
anonymised prior to analysis. The requirement of ethical approval of this study involving
human subjects has been waived by the local medical ethics review committee.
The CT scans from AMC (voxel size: 0.9375×0.9375×3 mm3) were acquired on a
GE Lightspeed RT 16 CT machine and the CT scans from UMC Utrecht (voxel size
0.9805×0.9805×3 mm3) were acquired on a Philips Brilliance Big Bore 16 CT machine.
Patients’ ages at the time of scanning ranged from 2.1 to 5.6 years, as Wilms’ tumor mostly
occurs within this age group [22]. The patients were diagnosed with different types of
childhood tumors with Wilms’ tumor as the largest disease category (21 out of 35).
In Wilms’ tumor patients, mostly, only one kidney is affected, making the other kidney
an OAR during RT. Consequently, CT scans of patients who underwent nephrectomy at one
side cannot be used as a surrogate CT for RT plans irradiating the kidney bed at the other side.
Two groups of patients were thus formed (figure 1(1-A)): GL consisting of patients with an
intact left kidney and GR consisting of patients with an intact right kidney present in the CT.
Further, 13 patients with both intact kidneys were included in both groups. In total, each
group consisted of 24 patients. We selected four right-sided Wilms’ tumor plans for GL and
four left-sided Wilms’ tumor plans for GR as reference RT plans. The associated reference
CTs are from patients treated at various ages: two ∼3-year-old patients, four ∼4-year-old
patients, and two ∼5-year-old patients. Since the RT treatment protocol for Wilms’ tumor
remained virtually the same from the pre-1990 era until now [25, 26], the RT plans used in
this study and the corresponding results are a solid basis for applying our approach to patients
treated in the 2D-era with historical plans.
Detailed information of patient characteristics and patient grouping can be found in
table 1.
OARs including the liver, spleen, kidney(s), and spinal cord [22], were manually deli-
neated (Velocity, version 3.2.0, Varian Medical Systems, Inc., Palo Alto, CA, US) by two
experienced RT technologists and checked by a radiation oncologist. In order to compare the
organ volume and organ dose in the spinal cord, we delineated a sub volume of the spinal
cord (which is present in all included CT scans) using the vertebrae as a reference. This sub
volume starts at the 10th thoracic vertebra and ends at the 1st sacrum vertebra. From this point
on, the term spinal cord refers to this specific sub volume.
2.2. Plan reconstruction and dose calculation
We selected reference plans of recently-treated patients that were found to be representative of
historical Wilms’ tumor plans. These plans used an AP-PA field set up, with a prescribed dose
of 14.4 Gy applied in eight fractions. According to the clinical SIOP WT 2001 protocol [27],
the treatment field of a typical right-sided Wilms’ tumor covers the tumor region including the
vertebral column, the iliac crest, and major parts of the right liver, whereas the treatment field
of a typical left-sided Wilms’ tumor covers the major part of the left flank with the vertebral
column, the left part of the liver, and the spleen. RT plan field characteristics of the selected
reference plans are provided in table 1.
To simulate the historical treatment based on 2D simulator films, the AP-PA field shapes
of each reference RT plan were visualised on DRRs that were derived from the corresponding
reference CT Rscan. This was achieved by applying a standard rendering method from
Oncentra treatment planning system (TPS) (version 4.3, Elekta, Stockholm, Sweden). To
mimic the contrast in historical simulator films, we selected an enhancement setting (min/
max CT data threshold −300/3095, center 1500, width 3000, bone threshold 100, and bone
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Table 1. Overview of patient characteristics, grouping, usage as reference, and the field features of the reference RT plans.
Patient ID Group
Age
(years) Gender
Height
(cm)
Weight
(kg) Tumor site
Used as reference
(Plan ID)
Field cranial/
caudal borders
Blocked region
border
1 GL/GR 2.2 M 90 15 Right suprarenal gland N
2 GL 2.3 F 90 12 Left suprarenal gland N
3 GL 2.4 M 89 13 Right kidney N
4 GR 2.5 F 93 14 Left kidney GR(1) Th8/S1 S1
5 GL/GR 2.6 F 92 13 Left suprarenal gland N
6 GL/GR 2.8 F 105 12 Left suprarenal gland N
7a GR 2.8 M 98 18 Left kidney N
8 GR 2.9 F 98 13 Right kidney N
9 GL 3.0 M 92 13 Right kidney N
10 GR 3.1 M 92 10 Left kidney N
11 GL 3.2 F 99 16 Right kidney GL(1) Th8/L4 Th8
12a GR 3.2 F 95 13 Left kidney N
13 GL 3.3 M 96 15 Right kidney N
14 GL/GR 3.3 M 106 17 Ductus choledochus N
15 GR 3.5 F 98 15 Bilateral kidneys N
16 GL 3.6 F 98 14 Right kidney N
17 GL/GR 3.7 M 101 14 Right lower abdomen N
18 GL 3.8 M 102 15 Right kidney GL(2) Th12/L4 Right rib 11
19 GR 3.8 M 104 18 Left suprarenal gland N
20 GL 3.9 F 108 18 Right kidney GL(3) Th8/L4 Right
rib 8-Th9
21 GL/GR 3.9 M 100 17 Retroperitoneal N
22 GR 4.2 F 115 20 Left kidney GR(2) Th10/L4 Left rib 10
23 GR 4.2 F 101 16 Left kidney N
24 GR 4.2 M 106 16 Left kidney GR(3) Th11/L4 Left rib 10
25 GL/GR 4.7 M 119 23 Left suprarenal gland N
26 GL 4.8 F 110 15 Right kidney N
27 GL/GR 4.8 F 103 17 Pelvic region N
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Table 1. (Continued.)
Patient ID Group
Age
(years) Gender
Height
(cm)
Weight
(kg) Tumor site
Used as reference
(Plan ID)
Field cranial/
caudal borders
Blocked region
border
28 GL/GR 4.9 M 105 18 4th ventricle N
29 GL 4.9 M 123 28 Right kidney GL(4) Th11/L4 Right rib 10
30 GL/GR 4.9 F 110 22 Para-aortic metastasis of
WT left kidney
N
31 GL/GR 5.1 M 109 17 4th ventricle N
32 GR 5.2 M 116 18 Left kidney GR(4) Th11/L5 Left rib 10
33 GL/GR 5.2 F 115 24 Left suprarenal gland N
34 GR 5.3 F 117 22 Left kidney N
35 GL/GR 5.6 F 113 20 4th ventricle N
Abbreviations and notations: F=female; M=male; Th1 through Th12 represent the 12 thoracic vertebrae; L1 through L5 represent the five lumbar vertebrae; S1 through S5 represent
the sacral vertebrae.
a Data from UMC Utrecht.
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enhancement factor 2.5) that gives similar contrast (based on a visual check) as in historical
simulator films.
Each reference RT plan was reconstructed on the other 23 patients’ CT scans in the
respective group. The reference patient’s CT scan on which the plan was originally applied
and the associated calculated dose are referred to as CTref and reference dose. The surrogate
patients’ CT scans and the calculated doses in the respective group are referred to as CTsur
scans and reconstructed doses for that reference plan. Since for each group there are four
reference patients, a CTref is at the same time a CTsur for the other three reference plans.
A reference plan was reconstructed on CTsur scans in Oncentra TPS as described in our
previous study [21]. First, we duplicated the reference plan and positioned it on CTsur with
necessary adjustments to correct for anatomical differences as visible between the DRR
derived from the CTsur and the reference DRR. (figure 1(2)). We then scaled the monitor units
to make the dose at the field isocenter the same as in the reference plan [28]. The adjusted
plans were checked by an experienced pediatric radiation oncologist (BVB).
We chose a treatment unit in our current TPS (Elekta Linac with a multi-leaf collimator
beam limiting device, energy: 6 MV) that is similar to the historical ones, and calculated all
the doses for both CTref and CTsur scans to enable a consistent comparison. For reference RT
plans that included the use of blocks that are no longer available in the current TPS, we used a
multi-leaf collimator (leaf width 0.5 cm) as a substitute to shape the block contour. For all
plans, a collapsed cone algorithm was used to calculate the dose, which is considered accurate
at in-field and near-field dose [29].
2.3. Deviations in patient characteristics and internal anatomical features
Independent from the organ dose reconstruction, the deviations in patient characteristics and
internal anatomical features (organ volume, organ location, and organ spatial overlap)
between the surrogate and reference patients/CTs were measured (figure 1(3)).
2.3.1. Deviations in patient characteristics. We calculated the signed difference in patient
age, height, and weight between surrogate patient and reference patient based on table 1.
2.3.2. Deviations in patient internal anatomy
2.3.2.1. Pre-processing: transform surrogate OARs to reference anatomy. For each reference
plan, we applied a preprocessing step to transform the OAR contours associated with the
CTsur scans to the coordinate system of the CTref (see figure 2). This is needed to be able to
compute deviations in anatomical features correctly, i.e. discounting for positioning
differences. To achieve this, we use image registration techniques. Specifically, since the
localisation and adaptation of the treatment plan used the vertebrae and the body shape as
reference anatomy visible in DRRs, the registrations were based on the spinal cord, an OAR
fixed inside the vertebrae, and the body contours. Two different types of registration were
performed: without and with scaling of the contours. The first type of registration was solely
performed on the spinal cord, to ensure alignment of all the patients. The latter was performed
on the combination of the spinal cord and the body contour, with the possibility to
additionally shrink/expand the CTsur. This enables us to consider only the residual anatomical
deviations after the field adjustment was performed in the dose reconstruction, because that
partly corrects for anatomical deviations in bony anatomy and body size.
Given a reference plan, the steps to transform OAR contours were:
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(1) Convert OARs and body contours of each CT scan to binary images using the
Visualisation Toolkit [30]. The binary images of the contours allow the registration
methods (in step 2) to solely focus on the shape of the contours.
(2) Perform automatic Euler (no scaling) or affine (allow scaling) registration using Elastix
software [31]. The binary images of the spinal cord, and of the spinal cord combined with
the body contour, for non-scaled and scaled registration, respectively, of each CTsur were
registered to that of the CTref.
(3) Apply the deformation vector fields obtained from the registrations to the remaining
binary images of OARs of CTsur, to transform surrogate OARs to the coordinate system
of the CTref.
Now all the OARs (non-scaled or scaled) are aligned in the coordinate system of CTref
(see figure 2).
The anatomical deviations between the reference and surrogate CTs were measured
based on the non-scaled and scaled contours. In the remainder, the notation O refers to the
original non-scaled surrogate OARs, and the notation S refers to the scaled version of
surrogate OARs.
2.3.2.2. Volume. The organ volume of an OAR was quantified based on the respective OAR
contour. Organ volume deviation for an OAR was computed as the (signed) difference
between the volume of the reference OAR and the one of the surrogate OAR, for both O
and S.
2.3.2.3. Location. Organ locations were defined by the geometrical center of the OARs after
alignment of the two contour sets based on the registration of the spinal cord (in the case for
scaled contours, combined with the body contour), as described above. The deviation in organ
Figure 2. Illustration of transforming an OAR (in this example the left kidney) from a
surrogate anatomy to the coordinate system of a reference anatomy based on
registration of the spinal cord and outer body contour. Note: in the image, the shape of
the vertebral column instead of the spinal cord is used for illustration purpose.
J. Radiol. Prot. 39 (2019) 598 Z Wang et al
606
location between the surrogate OARs and reference OARs was measured as signed difference
along: right-left (RL), AP, cranial-caudal (CC) as well as the Euclidean distance.
2.3.2.4. Spatial overlap. Spatial overlap after alignment of geometrical centers of OARs:
DSC1. The first type of spatial overlap of OARs was assessed by calculating the Dice
similarity coefficient (DSC) of the reference OAR contour and the surrogate OAR contour,
after alignment of the geometrical centers of the two contours (no rotation performed). This
measurement is commonly done to assess agreements in organ shape [32].
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where OARref refers to the reference OAR and OARsur refers to the surrogate OAR. V denotes
the volume of the corresponding region. DSC1 was computed both for O and S.
Spatial overlap after alignment of spinal cord (and body contour) of the respective CTs:
DSC2. In a dose reconstruction case, the anatomical deviations in OAR volume, shape, and
location will influence the reconstruction quality in a joint fashion. Thus, we additionally
considered a second type of spatial overlap measurement by directly calculating the DSC of
the OARsur and OARref, after they were pre-processed as described above, without aligning
them on the center of mass. To distinguish from the previously introduced DSC1 after
alignment of the geometrical centers, we denote this DSC as DSC2. Similarly, DSC2 was
computed both for O and S.
2.4. Data analyses
The organ mean dose was calculated in the reconstructed and the reference plans. To assess
the level of agreement between the reconstructed and the reference dose, we computed
absolute deviations in organ mean dose (DEmean, in Gy) for each OAR by subtracting the
reconstructed mean dose from the reference mean dose for that organ. In addition, the relative
DEmean was computed as DEmean divided by the reference organ-specific mean dose (reported
in %). The average deviation magnitude was also reported (i.e. |DEmean| in Gy and in %).
The anatomical deviations in organ volume, location, and spatial overlap based on the
non-scaled OARs and scaled OARs between each reference patient and all associated sur-
rogate patients were computed. As it is reasonable to expect the deviations based on scaled
OARs to be smaller (in the case of DSC larger values indicate smaller deviations) in absolute
values than the ones based on non-scaled ones, a paired one-sided t-test was performed to test
this hypothesis, using statistical significance set at p<0.05.
So far, deviations between the reference and surrogate anatomies of three patient char-
acteristics (age, height, and weight) and seven internal anatomical features (organ volume,
organ location in RL, AP, and CC directions and Euclidean distance, OAR spatial overlap
DSC1 and DSC2) were introduced. Deviations in patient characteristics were measured based
on the original data. Deviations in the anatomical features were measured based on both non-
scaled and scaled OARs. Therefore, in total 17 types of deviations were generated. We
calculated the Pearson’s correlation coefficients of the 17 types of characteristic/feature
deviation with DEmean. For deviations that can only be positive (i.e. Euclidean distances,
DSCs), their correlations with |DEmean| were tested.
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3. Results
3.1. Organ dose reconstruction results
Boxplots of the reconstructed organ mean doses together with the reference organ mean dose
for each reference plan are presented in figure 3. The average |DEmean| in Gy and relative
|DEmean| in % are summarised in table 2.
For GR plans (i.e. plans among patients with an intact right-sided kidney, i.e. primary
left-sided Wilms’ tumor), the reference mean liver doses vary from 2 to 6 Gy and the average
liver |DEmean| values for the reconstructions vary from 0.7 to 1.2 Gy (relative |DEmean| 14%–
32%). The reference mean spleen doses vary from 7 to 14 Gy for GR plans and large
deviations were found in the reconstructions, with the average |DEmean| values from 0.2 to 3.7
Gy (relative |DEmean| 1%–34%). For GL plans, the reference mean liver doses vary from 4 to
13 Gy, and the average |DEmean| values for the reconstructions vary from 1.6 to 3.2 Gy
(relative |DEmean| 16%–41%). The reference mean spleen doses are low (<1 Gy) for GL plans
and average |DEmean| values <0.3 Gy were found in the reconstructions (relative |DEmean|
22%-78%). For both GR and GL plans, the contralateral kidneys have a relatively low
reference mean dose (<3 Gy), and small average |DEmean| values (<1 Gy) were obtained for
the kidneys in the reconstructions, while the relative |DEmean| values (>18%) were com-
parable to the liver and the spleen. For both GL and GR plans, the reference mean spinal cord
doses are relatively high (>8 Gy), meanwhile, small average |DEmean| values were obtained
in the spinal cord in the reconstructions (<1 Gy, relative |DEmean| <10%).
3.2. Internal anatomical deviations
The distribution of the geometrical centers of all the OARs, when aligned by the geometrical
center of the spinal cord of each CT (without scaling), is presented in figure 4. The average
anatomical deviations and the p-values of the one-sided t-test comparing the deviations based
on the non-scaled and scaled OARs are summarised in table 3.
We observed that for the liver, spleen, and right kidney 4/7 of the feature deviations were
significantly reduced using scaled OARs compared to non-scaled OARs. For the left kidney,
no significant differences were found (p>0.05). Of note, no comparison of deviations in
anatomical features for the spinal cord is provided as the spinal cord was used as reference to
align or scale the patient anatomies.
3.3. Correlations
The top three highest correlations between the deviation in characteristics/features and
DEmean (or |DEmean|) (Pearson’s R-squared) are summarised per OAR for each GL and GR
plans in figure 5. For the liver, in general, the features that correlate most with DEmean are
organ location in AP direction for GR plans, and organ location in CC direction for GL plans.
For the spleen, in general, organ location in CC direction correlates most with DEmean for GR
plans and organ location in RL correlates most with DEmean for GL plans. For the right
kidney, only organ location in RL direction has a moderate correlation with DEmean for all the
reference GR plans. For the left kidney and the spinal cord, none of the features had an
R2>0.5 correlation with DEmean (or |DEmean|). There are differences in the most three
correlated features among the same type (GR or GL) of plans. For instance only for reference
plan GR(3), a moderate to strong correlation (R
2>0.5) between DSC2 and |DEmean| for the
liver and the spleen, and between Euclidean distance and the |DEmean| for the spleen can be
observed. Also, only for reference plan GR(1), a moderate correlation (R
2>0.5) is found
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Figure 3. Boxplot of the reconstructed organ mean dose per reference plan. The
whiskers extend to the 10th and 90th percentiles, the boxes extend from the 25th to the
75th percentiles, the thick horizontal line inside the box indicates the 50th percentile
(i.e. the median), and the circles indicate outliers. The red line indicates the reference
organ mean dose. We combined the boxplots for the right kidneys in GR and the left
kidneys in GL reference plans in one row.
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between DSC2 and |DEmean| for the right kidney. The results further indicate no or only a very
small correlation (R2<0.5) between deviation in patient age, height, or weight and DEmean.
Regarding the difference between scaled and non-scaled OARs, of the 21 times that
deviations in anatomical features were found to be correlated with DEmean (or |DEmean|) with
Pearson’s R-squared >0.5, 16 times a stronger correlation was found for feature deviations
based on scaled OARs compared to non-scaled OARs and, only 5 times it was the other way
around.
For each type of the plan (GR/GL), we selected the anatomical feature that on average
had the largest correlation among the four reference plans. Scatter point plots of the deviation
in the anatomical feature versus DEmean (or |DEmean|) for four OARs are presented in figure 6.
Plots for the spinal cord were not included because no correlations (R2<0.4) between
feature deviations and DEmean were found. When the mean organ dose is small (e.g. for the
right kidney and the spleen for GL plans), even in case of a strong correlation between
deviation in the feature and deviation in DEmean, the scatter plots still illustrate small slopes.
4. Discussion
In this study, for the first time to our knowledge, the relation of deviations in organ dose
reconstruction using surrogate CT scans with deviations in patient characteristics such as age,
height, and weight, and internal anatomical features such as organ location was compre-
hensively investigated. The focus was on Wilms’ tumor RT plans from childhood cancer
patients with an age range of 2–6 years during treatment.
Our analysis indicates that the performance of organ dose reconstruction using surrogate
childhood cancer patients’ CT scans is not consistently highly correlated to any of the tested
features. In general, it is primarily related to organ location, organ volume, and spatial overlap
of organs, and not related to patient age, height and weight. Further, it is dependent on the
particular RT plan. These findings will guide the selection/construction of a surrogate
anatomy to ensure accurate dose reconstruction.
A large variety in the DEmean values was observed for the liver and the spleen for the
investigated reference RT plans. For the liver and the spleen, organ location in all three
directions were found to be the features that correlated most with organ DEmean. This can be
explained by the OAR location relative to the reference RT field: the liver and the spleen (for
GR plans) were mostly located on the edge of the field (i.e. ∼1/3–2/3 organ volume inside
Table 2. Average organ |DEmean| (in Gy and in relative values %) of dose recon-
structions obtained for each reference plan.
Reference plans Liver Spleen Left Kidney Right Kidney Spinal cord
GR(1) 0.7 Gy, 14% 0.2 Gy, 1% 0.6 Gy, 36% 0.9 Gy, 8%
GR(2) 1.2 Gy, 22% 2.5 Gy, 32% 1.2 Gy, 59% 0.4 Gy, 4%
GR(3) 1.2 Gy ,32% 3.7 Gy, 29% 0.4 Gy, 25% 0.4 Gy, 5%
GR(4) 0.8 Gy, 31% 2.5 Gy, 34% 0.3 Gy, 21% 0.3 Gy, 3%
GL(1) 1.8 Gy, 16% 0.1 Gy, 22% 0.3 Gy, 18% 0.5 Gy, 4%
GL(2) 1.6 Gy, 41% 0.1 Gy, 25% 0.4 Gy, 24% 0.3 Gy, 4%
GL(3) 3.2 Gy, 25% 0.3 Gy, 33% 0.7 Gy, 25% 0.9 Gy, 7%
GL(4) 2.2 Gy, 35% 0.3 Gy, 78% 0.6 Gy, 24% 0.5 Gy, 5%
Average 1.6 Gy, 27% 1.2 Gy, 32% 0.5 Gy, 23% 0.6 Gy, 35% 0.5 Gy, 5%
Note: the reported values were rounded to 0.1 Gy and 1%.
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Figure 4. OAR geometrical center distributions in coronal view (a) and sagittal view
(b), when the OARs (based on delineations) of each CT are aligned by the geometrical
center of the spinal cord (black cross). Each non-filled symbol represents the
geometrical center of an OAR associated with a CT included in this study. The filled
symbols of each type represent the average locations of the OARs. The shapes of the
OARs were added for illustration purpose.
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Table 3. Average deviations in OAR volume, OAR location (in three directions and in terms of Euclidean distance), and organ spatial overlap
(DSC1 and DSC2) between reference and surrogate OARs, based on non-scaled and scaled OARs; and the p-value of the one-sided paired t-test
based on non-scaled and scaled OARs (significance threshold: 0.05).
OAR Liver Spleen Right kidney Left kidney
Feature O S p O S p O S p O S p
Volume (cm3) 133 109 0.01 35 39 NS 29 27 NS 24 31 NS
RL (mm) 14 12 <0.001 9 5 <0.001 5 4 0.03 3 4 NS
AP (mm) 9 10 NS 8 8 NS 4 3 NS 3 4 NS
CC (mm) 11 13 NS 14 12 0.02 11 11 NS 11 11 NS
Euclidean distance (mm) 23 22 NS 20 18 <0.001 14 13 0.01 13 14 NS
DSC1 0.70 0.72 <0.001 0.61 0.61 NS 0.74 0.75 0.02 0.76 0.75 NS
DSC2 0.60 0.68 <0.001 0.39 0.49 <0.001 0.57 0.59 0.01 0.64 0.61 NS
Abbreviations: O=Original (non-scaled) contours; S=Scaled contours; p=p-value; NS=not significant (when p-values >0.05).
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the field), where a steep dose gradient is present. Moreover, the liver and the spleen were
found to have a larger organ location variation compared to the kidneys (figure 4). The
contralateral kidneys, with only a small part of the volume in-field for the reference RT plans,
received a low mean dose and were found to have smaller |DEmean| but similar relative
|DEmean| compared with the liver and the spleen. At the same time, there are also differences
between the two kidneys. The right kidney, which is located more caudally than the left
kidney to accommodate the liver, was found to have larger |DEmean| and smaller DSC2 values
Figure 5. The three highest squared Pearson’s correlation coefficients (i.e. R-squared)
between deviations in patient characteristics/anatomical features and DEmean (or
|DEmean|, if the deviation characteristic/feature has a scalar quantity) for OARs are
presented as lollipop plots for each reference plan in GR (a) and GL (b). Text following
each lollipop indicates the characteristic/feature. The solid or open circle of a lollipop
indicates whether the characteristic/feature is scaled or not.
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than the left kidney. While moderate correlations between anatomical features deviations (e.g.
location in CC direction, DSC2, and organ volume) and DEmean (or |DEmean|) were found for
the right kidney, no clear correlations were found for the left kidney. Similar to the left
kidney, small DEmean values were obtained for the spinal cord (average |DEmean| <1 Gy,
relative <1%) and no correlations were found with any of the feature deviations. This could
be explained by the following facts: (1) the spinal cord is fixed in the vertebrae while the
positioning and adaptation of the RT fields is mainly based on bony anatomy of the vertebrae,
and (2) the spinal cord is an inevitable in-field OAR according to field definitions due to its
anatomic vicinity to the affected kidney. The spinal cord thus received a highly homogeneous
Figure 6. Scatter plots of the feature deviations versus DEmean for which the largest
correlations were found for reference plans in GR (a) and GL (b). Each point represents
one reconstruction case, with color and shape referring to the reference plan.
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dose that is insensitive to small shape/size variations. Generally speaking, when the DEmean is
small, it is hard to find its correlation with deviation in the considered characteristics/features.
To summarise, the quality of organ dose reconstruction is not only affected by the anatomical
deviations respective to the reference anatomy, but also affected by anatomical variations, in
particular organ location, respective to the field borders (e.g. in-field, on the edge of the field,
or near-field).
Since there is a steep dose gradient on the field boundary, the field site (left/right) and
shape of the Wilms’ tumor reference plan influenced the correlations between feature
deviations and DEmean. For example, the field of reference plan GR(1), with 8th thoracic
vertebra and 1st sacral vertebra as the cranial and caudal field borders, respectively, fully
covered the spleen in CTref and CTsur scans. Therefore, reconstructed mean doses for the
spleen were virtually the same; accordingly, no strong correlation was found between the
deviation in anatomical features and the dose deviation in the spleen. For plans where a larger
part of the liver/spleen is intersected by the cranial field border than by the left/right field
border, DEmean for liver/spleen is more sensitive to organ location deviations along CC
direction than along RL direction (see figure 6). Also, organ location variations were larger
along the CC direction than along the AP and RL directions. This can be partly explained by
the difference in stages of respiration captured in the CT scans, as respiration-induced organ
motion mainly occurs along the CC direction [33].
In addition to variation in organ location, variations in organ volume and spatial overlap
after alignment of the geometrical organ centers (i.e. DSC1) represent OAR anatomical
variations that were expected to additionally contribute to the reconstructed dose deviations.
However, the results of the correlation tests showed that deviation in these features does not
generally correspond to deviation in mean dose. It indicated that these features alone do not
dominate the organ mean dose accuracy, especially when the geometrical center of the OARs
have large variations (in the case for the liver and the spleen). Furthermore, Euclidean
distance and DSC2 are measurements that combine organ location distances in three direc-
tions, and organ volume, location, and spatial overlap differences, respectively. There were
also no (moderate) correlations found between deviation in these features and |DEmean|.
Considering the definition of the measurements, they were isotropic in measuring dissim-
ilarity in anatomy: a deviation in organ location to the right and the left could result in the
same value for both the Euclidean distance and DSC2. However, the relative location of the
RT field to an OAR is anisotropic: displacement in different directions could lead to a totally
different dosimetric change.
The low correlations found for deviations in age, height, and weight with DEmean suggest
that these features are insufficiently specific indicators of a surrogate CT to ensure accurate
organ dose reconstruction. Thereby, this study confirms and extends the findings from our
previous work that indicated that using only age and gender as matching criteria in organ dose
reconstruction using surrogate childhood cancer patients’ CT scans is not sufficient [21].
The patient characteristics age, height, and weight were analyzed because they are
commonly investigated in phantom-based dose reconstruction studies for matching a patient
with a phantom [14, 34]. Organ volume was included as a commonly used measurement for
organ variation between patients. Organ location deviations were quantified not only in terms
of Euclidean distance, but also in three orthogonal directions separately, to provide insight on
displacements with certain directions. Two types of spatial overlap were included to provide
overall assessments on OAR similarity combining similarity in organ volume and shape with
orientation (DSC1) and with organ location (DSC2). In a previous feasibility study from our
group that used machine learning techniques to predict anatomical similarity from available
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features of historically-treated patients [23], several notions of patient similarity were pro-
posed. However, these notions of patient similarity were not validated in terms of dose
reconstruction accuracy, which is ultimately the goal of dose reconstruction. Some similarity
notions are not included in this article such as the Hausdorff distance between two aligned
OAR contours, so-called overall organ constellation, and a modification of the organ volume
histogram overlap (OVH), an isotropic measurement of organ overlap that is similar to the
concept of DSC2 [35]. In preliminary studies, we found that the Hausdorff distance was
highly correlated with the DSC and resulted in similar correlations with dose deviations. For
the OVH we did not find better correlations with deviations in dose than for DSC2. As we
believe that DSC2 represents a more direct and easy-to-understand overlap measurement, we
presented DSC2 instead of OVH. Furthermore, no correlation between the overall organ
constellation (sum of square of pairwise Euclidean organ distances) and the deviation in organ
mean dose was found in our preliminary study.
In this study, anatomical deviations were measured based on both the original non-scaled
and scaled OARs. The option where the OARs of the surrogate CT were scaled with respect
to the spinal cord and body contour of the reference anatomy was investigated because the
reference plans were also ‘rescaled’ based on the visible anatomy in a 2D image (described in
section 2). The comparison of the results showed that anatomical deviations between sur-
rogate and reference OAR were typically reduced when based on the scaled OAR except for
the left kidney. Also, stronger correlations between deviations in features and deviations in
organ mean dose were found based on scaled OARs than non-scaled OARs. It might,
therefore, be of interest for future studies concerning the selection of similar patients/ana-
tomies, to consider using scaled anatomies (based on 2D measurements), instead of original
anatomies. On the other hand, for example, for organ location along the AP direction for all
OARs, no significant reduction in deviation was found based on scaled contours compared to
non-scaled contours. Even for the significantly reduced anatomical deviations, they were not
eliminated: at most, scaling OARs reduced deviations for up to 50% of the deviations based
on non-scaled contours. These observations again indicate that internal organ anatomies were
not determined by the patient’s spinal cord and body contour.
A limitation of our study is the small number of patient data included, which provided a
limited spread of anatomical variations in the 2–6 years old age range. It is expected that more
statistically convincing, and probably stronger correlations will be found, once we include
more patients. Secondly, our study was focused on Wilms’ tumor plans and OARs in the
abdominal region. Nevertheless, as flank irradiation with AP-PA field set-up is typical in
historical RT planning for other types of abdominal cancers [1], we expect that the general
conclusions on characteristic/feature deviations in relation to dose deviations may also hold
for other type of abdominal RT plans. Furthermore, in this study we limited ourselves to
assessing the organ mean dose, which lacks the spatial information of a 3D dose distribution,
while 3D dose distributions would provide the potential to develop more detailed models
between treatment and late adverse effects. The anatomical variations of OARs between
patients precluded direct voxel-to-voxel dose comparisons between the reference and surro-
gate CT. A possible solution is to employ deformable image registration techniques to allow
for voxel-to-voxel dose comparison from two different anatomies. However, the use of
deformable image registration would introduce new forms of uncertainty which remain to be
quantified and, subsequently, need to be assessed in terms of their impact on dose recon-
struction applications [36].
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5. Conclusion
Internal anatomical deviations in organ location were found to primarily dominate dose
reconstruction outcomes in mean dose for OARs, however, the linear correlations were not
consistently high for all the investigated reference plans. Deviation in organ volume and
spatial overlap contributed to a lesser extent to the mean dose deviations in OARs. Patient
characteristics, such as age, height and weight were not linearly correlated with deviations in
DEmean. It is thus suggested that for organ dose reconstruction, efforts should be made to
predict these relevant anatomical features from available (2D) information, and to estimate the
extent of OAR coverage by the RT field based on RT plan features.
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